Tuesday, December 5, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Yeargan-Bate Professor of Medicine, Microbiology and Epidemiology
Associate Vice Chancellor for Medical Affairs and Global Health
Director, Institute for Global Health and Infectious Diseases
University Of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Professor of Medicine
Head, Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California, United States
Professor of Infectious and Tropical Diseases
Université Paris Cité
Paris, France
Professor of Medicine
Mayo Clinic College of Medicine
Vice Chair
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for primary care physicians, infectious disease/HIV specialists, allergists and clinical immunologists, pulmonologists, hematology/oncology specialists, nephrologists, and transplant surgeons.
The goal of this activity is that learners will be better able to understand the role of vaccines vs mAb therapies for both treatment and pre-exposure prophylaxis for COVID-19, and be brought up to date on the current mAbs and key clinical data.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Yeargan-Bate Professor of Medicine, Microbiology and Epidemiology
Associate Vice Chancellor for Medical Affairs and Global Health
Director, Institute for Global Health and Infectious Diseases
University Of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Professor of Medicine
Head, Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California, United States
Professor of Infectious and Tropical Diseases
Université Paris Cité
Paris, France
Professor of Medicine
Mayo Clinic College of Medicine
Vice Chair
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME Released: 11/11/2022
Valid for credit through: 11/11/2023, 11:59 PM EST
processing....
Download the pdf.
| « Return to: Monoclonal Antibody Therapies for SARS-CoV2: Are You Up to Date? |
